A Minimalist Design Looks Great for Clearing Tau
Interception of Extracellular Tau by Antibodies May Be Sufficient to Stop the Spread of Tau in AD
Spherical Nucleic Acids Deliver a New Package for Oliognucleotide Therapeutics
SNAs Are a Hopeful First Step in Boosting the Utility of Oligonucleotides to Treat a Variety of Human Diseases
Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
More GEN Content From This Contributor:
- Columns: Certainty Not Required for Inventorship
- Feature Articles: Patent Update: Redefining Written Descriptions for Patents
- Columns: Is Safe Harbor Closed to Research Tools?
- Columns: Patentability of Genetic Sequences Limited
- GEN Exclusives: Special Report: Patentability of Genetic Sequences Limited
- Columns: Patent Law Reform in the Works Again
- Columns: Difficulty in Patenting Improved Antibodies
- Columns: Personalized Medicine Diagnostic Patents
- Columns: Law of Nature or Patentable Discovery?
- Columns: Isolated Genes Remain Patentable
- Columns: Do Patents Control Self-Replicating Technologies?
- Columns: Evolving Standards for Patent Infringement
- Columns: Biotechnology Patent Validity in Jeopardy